BIOG — Biotech Growth Trust Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsBalancedSmall Cap
- £199.86m
- £191.41m
- -£77.53m
Annual cashflow statement for Biotech Growth Trust, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 201 | -202 | -41.2 | 74.8 | -82.5 |
| Non-Cash Items | -224 | 209 | 35.5 | -78.9 | 77.9 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 18.1 | -18.4 | -0.144 | -0.067 | -0.482 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.67 | -12.1 | -5.89 | -4.24 | -5.09 |
| Other Investing Cash Flow Items | -25.5 | 13 | 45.7 | 22.3 | 116 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -25.5 | 13 | 45.7 | 22.3 | 116 |
| Financing Cash Flow Items | -0.25 | -0.179 | -0.792 | -1.11 | -1.32 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 32.7 | -2.39 | -37 | -18.7 | -104 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.5 | -1.5 | 2.77 | -0.641 | 6.32 |